Changes have been proposed to the quality payment program that could have ups and downs, but not, perhaps for some, until ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Subgroup analyses of the PHOTON trial show visual acuity gains across subgroups by race, baseline visual acuity and retina ...

Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes ...

University of Washington’s Peter Rabinowitz, M.D., M.P.H.. sees a world awash in emerging diseases and climate change data ...

Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to ...

The list includes dengue fever, chikungunya, leptospirosis and Valley fever, says University of Washington professor Peter ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Up to half of patients showed significant improvement in study results presented at the American Academy of Ophthalmology ...

In the threat versus opportunity session, Cecilia and Aaron Lee of the University of Washington staked out opposing positions ...